Literature DB >> 16872162

Synthesis of an inhibitor-tethered resin for detection of active matrix metalloproteinases involved in disease.

Dusan Hesek1, Marta Toth, Viktor Krchnak, Rafael Fridman, Shahriar Mobashery.   

Abstract

Matrix metalloproteinases (MMPs), of which 26 members are known in humans, are implicated in a number of diseases. Their activity is strictly controlled, but when the biological control over the activity is lost, disease processes set in. In an attempt to delineate what MMP activity has gone awry in what diseases, including metastatic cancers that are of special interest to our laboratories, we conceived and synthesized two chromatographic resins incorporated with a multifunctional broad-spectrum inhibitor for MMPs. The broad-spectrum inhibitor contains three sterogentic centers and was synthesized in 13 steps. Two structural variants of the inhibitors were linked to the polymer support via disulfide moieties. These resins are intended for use in cellular systems to selectively fish out from a complex mixture of all cellular proteins the active MMP forms important for the specific disease for identification.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16872162     DOI: 10.1021/jo060058h

Source DB:  PubMed          Journal:  J Org Chem        ISSN: 0022-3263            Impact factor:   4.354


  6 in total

1.  A chemical biological strategy to facilitate diabetic wound healing.

Authors:  Major Gooyit; Zhihong Peng; William R Wolter; Hualiang Pi; Derong Ding; Dusan Hesek; Mijoon Lee; Bill Boggess; Matthew M Champion; Mark A Suckow; Shahriar Mobashery; Mayland Chang
Journal:  ACS Chem Biol       Date:  2013-09-26       Impact factor: 5.100

2.  MMP-1 and ADAM10 as Targets for Therapeutic Intervention in Idiopathic Pulmonary Fibrosis.

Authors:  Zhihong Peng; Mohini Mohan Konai; Luis F Avila-Cobian; Man Wang; Shahriar Mobashery; Mayland Chang
Journal:  ACS Pharmacol Transl Sci       Date:  2022-07-18

3.  Matrix Metalloproteinase-14 as an Instigator of Fibrosis in Human Pterygium and Its Pharmacological Intervention.

Authors:  Cesar Masitas; Zhihong Peng; Man Wang; Mohini Mohan Konai; Luis F Avila-Cobian; Leslie Lemieux; John Hovanesian; James E Grady; Shahriar Mobashery; Mayland Chang
Journal:  ACS Pharmacol Transl Sci       Date:  2022-07-19

4.  Expression of active matrix metalloproteinase-9 as a likely contributor to the clinical failure of aclerastide in treatment of diabetic foot ulcers.

Authors:  Trung T Nguyen; Derong Ding; William R Wolter; Matthew M Champion; Dusan Hesek; Mijoon Lee; Rocio L Pérez; Valerie A Schroeder; Mark A Suckow; Shahriar Mobashery; Mayland Chang
Journal:  Eur J Pharmacol       Date:  2018-07-19       Impact factor: 4.432

5.  Fluorescent Analogue of Batimastat Enables Imaging of α-Secretase in Living Cells.

Authors:  Geoffray Leriche; Allen C Chen; Sumin Kim; Dennis J Selkoe; Jerry Yang
Journal:  ACS Chem Neurosci       Date:  2015-11-18       Impact factor: 4.418

6.  Targeting extracellular matrix remodeling sensitizes glioblastoma to ionizing radiation.

Authors:  Varsha Thakur; Vijay S Thakur; Brittany Aguila; Tatiana I Slepak; Man Wang; Wei Song; Mohini Konai; Shahriar Mobashery; Mayland Chang; Ayush B Rana; Dazhi Wang; Juliano Tiburcio de Freitas; Sakir Humayun Gultekin; Scott M Welford; Michael E Ivan; Barbara Bedogni
Journal:  Neurooncol Adv       Date:  2022-09-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.